← FDA Drug Approvals (Drugs@FDA)
LOPINAVIR AND RITONAVIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2024-02-07
Drug application
- FDA Application #
ANDA079074- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LOPINAVIR AND RITONAVIR
- Generic name
- Lopinavir
- Active ingredients
- LOPINAVIR; RITONAVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- First approval
- 2024-02-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown